Immunogen (NASDAQ:IMGN) reported its Q1 earnings results on Friday, May 6, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Immunogen beat estimated earnings by 52.38%, reporting an EPS of $-0.1 versus an estimate of $-0.21.
Revenue was up $22.37 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.54 which was followed by a 7.44% increase in the share price the next day.
Here's a look at Immunogen's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.71 | -0.18 | -0.18 | -0.19 |
| EPS Actual | -0.17 | -0.18 | -0.15 | -0.17 |
| Revenue Estimate | 25.65M | 19.03M | 18.92M | 17.73M |
| Revenue Actual | 27.99M | 9.21M | 16.95M | 15.71M |
To track all earnings releases for Immunogen visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
